Clin2
NCT04291768Possibly a fitRecruiting

Shorter 5-day antibiotics for certain gram-negative bloodstream infections

Gram-negative BacteremiaUrinary Tract Infection Bacterial

Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
380 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are over 18 years old
  • A blood test (blood culture) grew gram-negative bacteria
  • Your infection likely started in the urinary tract (urine culture positive or urinary symptoms)
  • You started a gram-negative–active antibiotic within 12 hours of the first positive blood culture
  • At the start of the study, you are stable (blood pressure, heart rate, breathing, and oxygen are not too low)
  • You can give informed consent (and you are not pregnant or breastfeeding)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06080698Recruiting
Oral antibiotics for bloodstream infection trial

This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.

San Francisco, California
NCT07202377Not yet recruiting
Faster antibiotic testing for ICU patients with bloodstream infections

This trial tests whether reporting antibiotic sensitivity results in under 6 hours helps doctors choose the right β-lactam antibiotic faster for ICU patients with certain bloodstream infections. If you are in the ICU with a Gram-negative infection, your doctors will use a quick test to pick the best treatment.

NCT07791914Not yet recruiting· Phase 4
Switching from IV to oral antibiotics for children with bloodstream infections

This trial tests whether children with a bloodstream infection can safely switch from intravenous (IV) antibiotics to oral (by mouth) antibiotics earlier, after showing improvement. It aims to reduce hospital stays and make treatment easier for children.

Aabenraa
NCT07322146Enrolling by invitation· Phase 4
Shorter antibiotics for children with common infections

This study tests whether shorter courses of antibiotics are as effective as longer ones for children hospitalized with pneumonia, skin infections, or urinary tract infections. It may help children get back to normal faster and reduce side effects.

Birmingham, Alabama
NCT07372131Recruiting
Shorter antibiotics for high-risk fever with low white blood cells

This study looks at how long antibiotics should be given to cancer patients with fever and very low white blood cell counts after finding a certain type of bacteria (Gram-negative) in their blood. The goal is to find the best treatment duration to help patients recover without complications.

Rozzano, Milan
NCT05597540Recruiting· Phase 3
Shorter antibiotics for kidney transplant kidney infections

This study compares giving antibiotics for 7 days versus 14 days to treat acute kidney infections (pyelonephritis) in people with kidney transplants. It aims to see if the shorter course works just as well and is safer or easier to complete.

Bordeaux

Hear when a new Gram-negative Bacteremia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.